IL163753A0 - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors

Info

Publication number
IL163753A0
IL163753A0 IL16375303A IL16375303A IL163753A0 IL 163753 A0 IL163753 A0 IL 163753A0 IL 16375303 A IL16375303 A IL 16375303A IL 16375303 A IL16375303 A IL 16375303A IL 163753 A0 IL163753 A0 IL 163753A0
Authority
IL
Israel
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
IL16375303A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL163753A0 publication Critical patent/IL163753A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16375303A 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors IL163753A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
IL163753A0 true IL163753A0 (en) 2005-12-18

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16375303A IL163753A0 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Country Status (28)

Country Link
US (1) US6806265B2 (pl)
EP (1) EP1506195B1 (pl)
JP (1) JP4230448B2 (pl)
KR (1) KR20050008716A (pl)
CN (1) CN1318421C (pl)
AR (1) AR040027A1 (pl)
AT (1) ATE412653T1 (pl)
AU (1) AU2003229186A1 (pl)
BR (1) BR0310033A (pl)
CA (1) CA2485916C (pl)
DE (1) DE60324418D1 (pl)
EA (1) EA009178B1 (pl)
EC (1) ECSP045432A (pl)
ES (1) ES2315492T3 (pl)
HR (1) HRP20041065A2 (pl)
IL (1) IL163753A0 (pl)
MX (1) MXPA04010409A (pl)
MY (1) MY134646A (pl)
NO (1) NO20044104L (pl)
NZ (1) NZ536736A (pl)
PE (1) PE20040365A1 (pl)
PL (1) PL371663A1 (pl)
RS (1) RS98004A (pl)
TW (1) TW200404071A (pl)
UA (1) UA79285C2 (pl)
UY (1) UY27809A1 (pl)
WO (1) WO2003097644A2 (pl)
ZA (1) ZA200406912B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
EP1610797A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
JP4845730B2 (ja) * 2003-07-17 2011-12-28 プレキシコン,インコーポレーテッド Ppar活性化合物
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
AU2005311925A1 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as PPAR PPAR active compounds
US20070072904A1 (en) * 2005-09-07 2007-03-29 Jack Lin PPAR active compounds
KR20080042170A (ko) * 2005-09-07 2008-05-14 플렉시콘, 인코퍼레이티드 Ppar 활성 화합물
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン,インコーポレーテッド Ppar活性化合物
US8492428B2 (en) 2005-09-20 2013-07-23 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
CA2968464A1 (en) 2014-11-25 2016-06-02 Bayer Pharma Aktiengesellschaft Substituted pyridobenzodiazepinone-derivatives and use thereof
KR20200030584A (ko) 2017-07-21 2020-03-20 앤타바이오 에스에이에스 화합물
TWI903299B (zh) 2018-03-08 2025-11-01 美商英塞特公司 作為PI3K-γ抑制劑之胺基吡嗪二醇化合物
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
CN118103038A (zh) * 2021-08-20 2024-05-28 英安塔制药有限公司 17β-羟基类固醇脱氢酶13型抑制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
TW200404071A (en) 2004-03-16
JP2005526851A (ja) 2005-09-08
EA200401482A1 (ru) 2005-06-30
CN1653066A (zh) 2005-08-10
US6806265B2 (en) 2004-10-19
KR20050008716A (ko) 2005-01-21
CA2485916A1 (en) 2003-11-27
DE60324418D1 (de) 2008-12-11
WO2003097644A3 (en) 2004-02-05
PE20040365A1 (es) 2004-07-22
ATE412653T1 (de) 2008-11-15
UY27809A1 (es) 2003-12-31
ZA200406912B (en) 2006-06-28
ES2315492T3 (es) 2009-04-01
CA2485916C (en) 2009-12-08
EA009178B1 (ru) 2007-12-28
HRP20041065A2 (en) 2005-04-30
US20040006071A1 (en) 2004-01-08
HK1080849A1 (en) 2006-05-04
NZ536736A (en) 2006-11-30
WO2003097644A2 (en) 2003-11-27
AU2003229186A1 (en) 2003-12-02
JP4230448B2 (ja) 2009-02-25
RS98004A (sr) 2006-12-15
AR040027A1 (es) 2005-03-09
PL371663A1 (pl) 2005-06-27
UA79285C2 (en) 2007-06-11
EP1506195B1 (en) 2008-10-29
MY134646A (en) 2007-12-31
ECSP045432A (es) 2005-01-03
CN1318421C (zh) 2007-05-30
BR0310033A (pt) 2005-02-15
MXPA04010409A (es) 2005-02-17
NO20044104L (no) 2004-12-01
EP1506195A2 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
EG25482A (en) Inhibitors
PL373649A1 (pl) Inhibitory kinazy
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
TWI372619B (en) Non-nucleoside reverse transcriptase inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP1558609A4 (en) KINASE INHIBITORS
ZA200406912B (en) Non-nucleoside reverse transcriptase inhibitors
EP1532133A4 (en) NF-: B INHIBITORS
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
AU7037001A (en) Non-nucleoside reverse transcriptase inhibitors
IL157543A0 (en) Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
EP1541580A4 (en) SULFOTRANSFERASE INHIBITORS
HRP20040886A2 (en) Non-nucleoside reverse transcriptase inhibitors
EP1326640A4 (en) NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
AU2002355614A1 (en) Non-nucleoside reverse transcriptase inhibitors
SI1294720T1 (sl) Nenukleozidni inhibitorji reverzne transkriptaze
HK1073113A (zh) 非核苷逆转录酶抑制剂
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
GB0226149D0 (en) Inhibitors
GB0224102D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors